Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
Chunyan Gu(Nanjing University of Chinese Medicine), Siegfried Janz(National Research Council Canada)
Cited by 37
Related Papers
Novel targeted deregulation of c-Myc cooperates with Bcl-XL to cause plasma cell neoplasms in mice
|Journal of Clinical Investigation|2004|105
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
|Molecular Cancer|2021|72
A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing
|Journal of Experimental & Clinical Cancer Research|2022|53
AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
|Journal of Experimental & Clinical Cancer Research|2022|32